NCT06219681

Brief Summary

In this project, the investigators use real-time fMRI neurofeedback (rtfMRI-nf) to causally relate dysfunction of right anterior insula (rAI) and right superior temporal sulcus (rSTS) connectivity with the intensity of repetitive negative thinking (RNT). The investigators hypothesize that rtfMRI-nf reducing rAI-rSTS connectivity would reduce RNT. The investigators propose a randomized double-blind, sham-controlled trial of rtfMRI-nf with 110 young adults (n=55/arm) with major depressive disorder (MDD) and high trait-RNT levels.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 12, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

January 12, 2024

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 23, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 4, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 4, 2025

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

June 17, 2026

Completed
Last Updated

June 17, 2026

Status Verified

May 1, 2026

Enrollment Period

1.2 years

First QC Date

January 12, 2024

Results QC Date

April 28, 2026

Last Update Submit

May 20, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Functional Connectivity Change Between Right Anterior Insular (rAI) and Right Superior Temporal Sulcus (rSTS) Within Visit1

    Functional connectivity between rAI and rSTS was assessed using psychophysiological interaction (PPI) analysis of fMRI BOLD signal. Beta-values derived from PPI analysis represent the strength of connectivity; higher positive values indicate stronger functional coupling between regions. Change scores were calculated as post-intervention beta-value minus pre-intervention beta-value within Visit 1. A negative value indicates reduced connectivity following neurofeedback.

    Immediately post-intervention during Visit 1 (day 1)

Secondary Outcomes (2)

  • Changes in Brief State Rumination Inventory (BSRI) Total Score From Pre- to Post-Intervention at Visit 1

    From baseline (pre-scan at Visit 1, Day 1) to immediately after neurofeedback intervention (post-scan at Visit 1, Day 1)

  • Change in Montgomery-Åsberg Depression Rating Scale (MADRS) Total Score From Baseline to Follow-up

    From baseline at Visit 1 (Day 1) to follow-up at Visit 2 (1 week after Visit 1)

Other Outcomes (1)

  • Functional Connectivity Change Between Right Anterior Insular (rAI) and Right Superior Temporal Sulcus (rSTS) From Visit1 to Follow-up (Visit 2)

    From baseline scan at Visit 1 (Day 1) to follow-up scan at Visit 2 (1 week after Visit 1)

Study Arms (2)

Active neurofeedback

EXPERIMENTAL

Receiving feedback signals from the repetitive negative thinking (RNT)-related brain functional connectivity

Behavioral: Active neurofeedback

Sham neurofeedback

SHAM COMPARATOR

Receiving artificially generated feedback signals.

Behavioral: Sham neurofeedback

Interventions

The session will be done on an individual basis. The active group will receive neurofeedback training from the repetitive negative thinking (RNT) related brain functional connectivity.

Active neurofeedback

The session will be done on an individual basis. The sham group will receive neurofeedback training from an artificially generated random feedback signal.

Sham neurofeedback

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Young adults ages 18-35
  • Participants who are able to give written informed consent prior to participation
  • Meeting DSM-5 diagnostic criteria for MDD who are currently depressed defined by the MINI
  • Participants who have RNT symptoms (Brooding subscale of Ruminative Response Scale: RRS-B ≥ 13)

You may not qualify if:

  • Moderate to severe traumatic brain injury (\>30 min. loss of consciousness or \>24 hours posttraumatic amnesia) or other neurocognitive disorder with evidence of neurological deficits
  • Presence of co-morbid medical conditions not limited to but including cardiovascular (e.g., history of acute coronary event, stroke), pulmonary, endocrine, neurological diseases (e.g., Parkinson's disease), or gastrointestinal illness, as well as pain disorders
  • Current significant suicidal ideation or suicide attempt within the previous 12 months
  • Current psychosis
  • Schizophrenia or schizoaffective disorder
  • Substance use disorder within the previous 12 months, except for mild alcohol, cannabis, or tobacco use disorder defined as less than 4 symptoms of the criteria for substance use disorder according to the MINI
  • Current diagnosis of post-traumatic disorder (PTSD) defined by the MINI
  • Severe claustrophobia
  • Bodily implants of unsafe paramagnetic materials such as pacemakers and aneurysm clips
  • Pregnancy
  • Current regular use of cardiovascular medications with a direct vasomotor effect, namely beta- or alpha-beta-blockers, clonidine, and antianginal agents.
  • Current use of more than three psychotropic medications
  • Evidence of recreational drug use from a urine test
  • Commencement of psychotropic medication for depression and/or anxiety less than a month before the study enrollment
  • Commencement of psychological therapy less than a month before the study enrollment
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Laureate Institute for Brain Research

Tulsa, Oklahoma, 74136, United States

Location

MeSH Terms

Conditions

Depressive Disorder, Major

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental Disorders

Limitations and Caveats

The study was terminated prematurely due to the Principal Investigator's departure, resulting in a smaller sample size than planned. Outcome measure data are based on available fMRI data after quality control exclusions and should be interpreted as preliminary.

Results Point of Contact

Title
Aki Tsuchiyagaito
Organization
Laureate Institute for Brain Research

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 12, 2024

First Posted

January 23, 2024

Study Start

January 12, 2024

Primary Completion

April 4, 2025

Study Completion

April 4, 2025

Last Updated

June 17, 2026

Results First Posted

June 17, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will not share

Locations